# 323 - CRISPR and the future of gene editing: scientific advances, genetic therapies, & more

**Channel:** Peter Attia MD
**Upload Date:** 2024-10-28
**URL:** https://www.youtube.com/watch?v=aOl0IDhzLCo
**Duration:** 138 minutes

## Description

View show notes here: https://bit.ly/3BVio8U
Become a member to receive exclusive content: https://peterattiamd.com/subscribe/
Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/

Feng Zhang, a professor of neuroscience at MIT and a pioneering figure in gene editing, joins Peter to discuss his groundbreaking work in CRISPR technology, as well as his early contributions to optogenetics. In this episode, they explore the origins of CRISPR and the revolutionary advancements that have transformed the field of gene editing. Feng delves into the practical applications of CRISPR for treating genetic diseases, the importance of delivery methods, and the current successes and challenges in targeting cells specific tissues such as those in the liver and eye. He also covers the ethical implications of gene editing, including the debate around germline modification, as well as reflections on Feng’s personal journey, the impact of mentorship, and the future potential of genetic medicine.

We discuss:
0:00:00 - Intro
0:01:32 - Feng’s background, experience in developing optogenetics, and his shift toward improving gene-editing technologies
0:10:05 - The discovery of CRISPR in bacterial DNA and the realization that these sequences could be harnessed for gene editing
0:21:48 - How the CRISPR system fights off viral infections and the role of the Cas9 enzyme and PAM sequence
0:29:48 - The limitations of earlier gene-editing technologies prior to CRISPR
0:39:08 - How CRISPR revolutionized the field of gene editing, potential applications, and ongoing challenges
0:51:59 - CRISPR’s potential in treating genetic diseases and the challenges of effective delivery
0:57:55 - How CRISPR is used to treat sickle cell anemia
1:05:51 - Gene editing with base editing, the role of AI in protein engineering, and challenges of delivery to the right cells
1:13:10 - How CRISPR is advancing scientific research by fast-tracking the development of transgenic mice
1:17:43 - Advantages of Cas13’s ability to direct CRISPR to cleave RNA and the advances and remaining challenges of delivery
1:27:55 - CRISPR-Cas9: therapeutic applications in the liver and the eye
1:40:15 - The ethical implications of gene editing, the debate around germline modification, regulation, and more
1:52:45 - Genetic engineering to enhance human traits: challenges, trade-offs, and ethical concerns
1:58:25 - Feng’s early life, the influence of the American education system, and the critical role teachers played in shaping his desire to explore gene-editing technology
2:13:15 - Feng’s optimism about the trajectory of science

--------
About:

The Peter Attia Drive is a deep-dive podcast focusing on maximizing longevity, and all that goes into that from physical to cognitive to emotional health. With over 90 million episodes downloaded, it features topics including exercise, nutritional biochemistry, cardiovascular disease, Alzheimer’s disease, cancer, mental health, and much more.

Peter Attia is the founder of Early Medical, a medical practice that applies the principles of Medicine 3.0 to patients with the goal of lengthening their lifespan and simultaneously improving their healthspan. 

Learn more: https://peterattiamd.com

Connect with Peter on:
Facebook: http://bit.ly/PeterAttiaMDFB
Twitter: http://bit.ly/PeterAttiaMDTW
Instagram: http://bit.ly/PeterAttiaMDIG

Subscribe to The Drive:
Apple Podcast: http://bit.ly/TheDriveApplePodcasts
Overcast: http://bit.ly/TheDriveOvercast
Spotify: http://bit.ly/TheDriveSpotify
Google Podcasts: http://bit.ly/TheDriveGoogle

Disclaimer: This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing, or other professional healthcare services, including the giving of medical advice. No doctor-patient relationship is formed. The use of this information and the materials linked to this podcast is at the user's own risk. The content on this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they have, and they should seek the assistance of their healthcare professionals for any such conditions. I take conflicts of interest very seriously. For all of my disclosures and the companies I invest in or advise, please visit my website where I keep an up-to-date and active list of such companies. For a full list of our registered and unregistered trademarks, trade names, and service marks, please review our Terms of Use: https://peterattiamd.com/terms-of-use/

## AI Summary

Here's my detailed analysis of this fascinating episode about CRISPR and gene editing:

1. **Executive Summary**:
This episode features Dr. Feng Zhang, a pioneer in CRISPR technology, discussing the evolution of gene editing, its current applications, and future potential. The conversation covers the technical aspects of CRISPR-Cas9 and Cas13 systems, their therapeutic applications, and the ethical considerations surrounding genetic modification. Dr. Zhang also shares his personal journey from China to Iowa and eventually becoming a leading figure in genetic engineering.

2. **Key Medical/Scientific Points**:
- CRISPR was initially discovered as bacterial immune system components in the 1980s [00:11:05]
- Cas9 protein is 1,300 amino acids long and works with guide RNA to target specific DNA sequences [01:23:14]
- Liver delivery efficiency can reach 80-90% using lipid nanoparticles [01:03:21]
- CRISPR-Cas13 specifically targets RNA rather than DNA [01:18:22]
- Current gene therapy applications focus on blood disorders, liver diseases, and eye conditions [00:57:38]

3. **Health Optimization Tips**:
Universal Recommendations:
- None specifically mentioned for general health optimization

Context-specific recommendations:
- Gene therapy for specific genetic conditions showing promise in liver and eye diseases [00:57:38]
- Sickle cell disease treatment through bone marrow modification [01:02:40]

4. **Supplements & Medications**:
No specific supplements discussed

Medications mentioned:
- PCSK9 inhibitors for cholesterol management [01:38:51]
- Gene therapy treatments for various conditions [00:57:38]

5. **Exercise & Movement**:
No specific exercise recommendations discussed

6. **Nutrition & Diet**:
No specific dietary recommendations discussed

7. **Biomarkers & Testing**:
- PCR testing for diagnostics [01:23:14]
- Genetic testing for disease mutations [00:41:52]

8. **References & Resources**:
Experts mentioned:
- Francisco Mojica - Early CRISPR researcher [00:14:53]
- Carl Deisseroth - Optogenetics pioneer [00:02:24]
- David Liu - Base editing developer [01:05:11]

9. **Notable Quotes**:
"The payload technology has come a long way... but the bottleneck is how do we put these really powerful payloads into the right cells in the right tissue in the body" [01:07:45]

10. **Follow-up Questions**:
- What are the current developments in delivery systems for gene editing technologies?
- How close are we to solving the size limitations of Cas proteins?
- What role will AI play in optimizing gene editing efficiency?
- How will cost barriers for gene therapy treatments be addressed?

Let me know if you would like me to expand on any of these sections or provide additional timestamps for specific topics.
